Ken Liao

22 papers and 414 indexed citations i.

About

Ken Liao has authored 22 papers that have received a total of 414 indexed citations. This includes 7 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. The topics of these papers are Biosimilars and Bioanalytical Methods (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). Ken Liao is often cited by papers focused on Biosimilars and Bioanalytical Methods (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Effects and risks of endocrine disrupting chemicals (4 papers) and collaborates with scholars based in United States, China and Singapore. Ken Liao's co-authors include Yu‐Mei Tan, Harvey J. Clewell, Donghua Yin, Melvin E. Andersen and Jason H. Williams and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics and Frontiers in Plant Science

In The Last Decade

Rankless by CCL
2025